CAPLIN POINT LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of CAPLIN POINT LABORATORIES have increased by 12.89% YoY .
The Earnings Per Share (EPS) of CAPLIN POINT LABORATORIES has increased by 19.56 % YoY. |
||
CAPLIN POINT LABORATORIES Last 5 Annual Financial Results
[BOM: 524742|NSE : CAPLIPOINT]
| Consolidated | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹2,187 Cr | ₹1,937 Cr | ₹1,694 Cr | ₹1,467 Cr | ₹1,269 Cr |
| Expenses | ₹1,426 Cr | ₹1,291 Cr | ₹1,143 Cr | ₹1,026 Cr | ₹875 Cr |
| Operating Profit (Excl OI) | ₹761 Cr | ₹647 Cr | ₹551 Cr | ₹441 Cr | ₹395 Cr |
| Other Income | ₹116 Cr | ₹96 Cr | ₹67 Cr | ₹57 Cr | ₹39 Cr |
| Interest | ₹0.87 Cr | ₹0.61 Cr | ₹0.78 Cr | ₹0.78 Cr | ₹0.70 Cr |
| Depreciation | ₹73 Cr | ₹66 Cr | ₹53 Cr | ₹45 Cr | ₹47 Cr |
| Profit Before Tax | ₹803 Cr | ₹677 Cr | ₹564 Cr | ₹451 Cr | ₹386 Cr |
| Profit After Tax | ₹650 Cr | ₹541 Cr | ₹461 Cr | ₹377 Cr | ₹308 Cr |
| Consolidated Net Profit | ₹641 Cr | ₹536 Cr | ₹457 Cr | ₹376 Cr | ₹300 Cr |
| Earnings Per Share (Rs) | ₹84.37 | ₹70.57 | ₹60.18 | ₹49.57 | ₹39.56 |
| PAT Margin (%) | 29.71 | 27.93 | 27.24 | 25.70 | 24.30 |
| ROE(%) | 20.79 | 21.72 | 22.97 | 23.68 | 24.77 |
| ROCE(%) | 24.97 | 26.22 | 26.92 | 26.85 | 28.77 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 21,357.9 Cr |
| Revenue (TTM) | : | ₹ 2,287.3 Cr |
| Net Profit(TTM) | : | ₹ 678.1 Cr |
| EPS (TTM) | : | ₹ 89.2 |
| P/E (TTM) | : | 31.5 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| CAPLIN POINT LABORATORIES | 11.6% | 8.7% | 34.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.9% | -2.3% | 21.8% |
| DIVIS LABORATORIES | -1.6% | 9.8% | 51.8% |
| TORRENT PHARMACEUTICALS | -2.6% | -2.3% | 37.5% |
| CIPLA | -2.2% | -6.1% | -12.5% |
| DR REDDYS LABORATORIES | -0.9% | -1.8% | -9.8% |
| MANKIND PHARMA | -2.9% | -4.2% | -6.9% |
| LUPIN | -3.1% | -11.7% | 12.5% |
| ZYDUS LIFESCIENCES | -3.5% | 1.3% | 14.6% |
CAPLIN POINT LABORATORIES Revenues
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 12.89 % |
| 5 Yr CAGR | 14.57 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,187 Cr | 12.89 | |
| Mar2025 | ₹1,937 Cr | 14.37 | |
| Mar2024 | ₹1,694 Cr | 15.50 | |
| Mar2023 | ₹1,467 Cr | 15.54 | |
| Mar2022 | ₹1,269 Cr | - | |
CAPLIN POINT LABORATORIES Operating Profit
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 17.61 % |
| 5 Yr CAGR | 17.84 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹761 Cr | 17.61 | |
| Mar2025 | ₹647 Cr | 17.32 | |
| Mar2024 | ₹551 Cr | 25.18 | |
| Mar2023 | ₹441 Cr | 11.66 | |
| Mar2022 | ₹395 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 4.19 % |
| 5 Yr CAGR | 2.86 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 34.79% | 4.19 | |
| Mar2025 | 33.39% | 2.58 | |
| Mar2024 | 32.55% | 8.39 | |
| Mar2023 | 30.03% | -3.38 | |
| Mar2022 | 31.08% | - | |
CAPLIN POINT LABORATORIES Profit After Tax
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 19.57 % |
| 5 Yr CAGR | 20.93 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹641 Cr | 19.57 | |
| Mar2025 | ₹536 Cr | 17.33 | |
| Mar2024 | ₹457 Cr | 21.48 | |
| Mar2023 | ₹376 Cr | 25.49 | |
| Mar2022 | ₹300 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 6.37 % |
| 5 Yr CAGR | 5.15 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 29.71 % | 6.37 | |
| Mar2025 | 27.93 % | 2.53 | |
| Mar2024 | 27.24 % | 5.99 | |
| Mar2023 | 25.7 % | 5.76 | |
| Mar2022 | 24.3 % | - | |
CAPLIN POINT LABORATORIES Earnings Per Share (EPS)
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | 19.56 % |
| 5 Yr CAGR | 20.85 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹84 | 19.56 | |
| Mar2025 | ₹71 | 17.26 | |
| Mar2024 | ₹60 | 21.40 | |
| Mar2023 | ₹50 | 25.30 | |
| Mar2022 | ₹40 | - | |
CAPLIN POINT LABORATORIES Return on Capital Employed (ROCE)
[BOM: 524742|NSE : CAPLIPOINT]
| Y-o-Y | -4.77 % |
| 5 Yr CAGR | -3.48 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 24.97% | -4.77 | |
| Mar2025 | 26.22% | -2.60 | |
| Mar2024 | 26.92% | 0.26 | |
| Mar2023 | 26.85% | -6.67 | |
| Mar2022 | 28.77% | - | |
CAPLIN POINT LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹2,810.3 |
| Current MarketCap | : | ₹ 21,357.9 Cr |
| Updated EOD on | : | Sep 04,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CAPLIN POINT LABORATORIES | 11.6% |
8.7% |
34.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
CAPLIN POINT LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 250 SMALLCAP INDEX | 0% | 0.8% | 10.1% |
| BSE 400 MIDSMALLCAP INDEX | -0.9% | -0.1% | 10.1% |
| BSE 1000 | -1% | -1.6% | 3.9% |
| BSE 500 | -1.1% | -1.9% | 3.1% |
| BSE HEALTHCARE | -1.3% | -0.1% | 16.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 MOMENTUM QUALITY 100 INDEX | -0.1% | 2.3% | 11.6% |
| NIFTY SMALLCAP 500 | -0.1% | 1.2% | NA |
| NIFTY SMALLCAP 250 | -0.1% | 0.9% | 12% |
| NIFTY MIDSMALLCAP400 50:50 | -0.8% | -0.1% | NA |
| NIFTY 500 EQUAL WEIGHT | -0.8% | -1.1% | 8.3% |
You may also like the below Video Courses
FAQ about CAPLIN POINT LABORATORIES Financials
How the annual revenues of CAPLIN POINT LABORATORIES have changed ?
The Revenues of CAPLIN POINT LABORATORIES have increased by 12.89% YoY .
How the Earnings per Share (EPS) of CAPLIN POINT LABORATORIES have changed?
The Earnings Per Share (EPS) of CAPLIN POINT LABORATORIES has increased by 19.56 % YoY .
Check out Intrinsic Value of Peers of CAPLIN POINT LABORATORIES
Compare Stock Analytics of Peers of CAPLIN POINT LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
